The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Regulation of muscle mass by growth hormone and IGF‐I
Open accessAbstract
Growth hormone (GH) is widely used as a performance‐enhancing drug. One of its best‐characterized effects is increasing levels of circulating insulin‐like growth factor I (IGF‐I), which is primarily of hepatic origin. It also induces synthesis of IGF‐I in most non‐hepatic tissues. The effects of GH in promoting postnatal body growth are IGF‐I dependent, but IGF‐I‐independent functions are beginning to be elucidated. Although benefits of GH administration have been reported for those who suffer from GH deficiency, there is currently very little evidence to support an anabolic role for supraphysiological levels of systemic GH or IGF‐I in skeletal muscle of healthy individuals. There may be other performance‐enhancing effects of GH. In contrast, the hypertrophic effects of muscle‐specific IGF‐I infusion are well documented in animal models and muscle cell culture systems. Studies examining the molecular responses to hypertrophic stimuli in animals and humans frequently cite upregulation of IGF‐I messenger RNA or immunoreactivity. The circulatory/systemic (endocrine) and local (autocrine/paracrine) effects of GH and IGF‐I may have distinct effects on muscle mass regulation. British Journal of Pharmacology (2008) 154, 557–568; doi:fn1
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Liu, J.-P., Baker, J., Perkins, A. S., Robertson, E. J., & Efstratiadis, A. (1993) · Cell · doi:10.1016/s0092-8674(05)80084-4 · Cited by 2,855
Role of insulin-like growth factors in embryonic and postnatal growth
Baker, J., Liu, J.-P., Robertson, E. J., & Efstratiadis, A. (1993) · Cell · doi:10.1016/s0092-8674(05)80085-6 · Cited by 2,463
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
FoxO3 Controls Autophagy in Skeletal Muscle In Vivo
Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S. J., Di Lisi, R., Sandri, C., Zhao, J., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.001 · Cited by 1,953
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583
Effects of Human Growth Hormone in Men over 60 Years Old
Rudman, D., Feller, A. G., Nagraj, H. S., Gergans, G. A., Lalitha, P. Y., Goldberg, A. F., Schlenker, R. A., Cohn, L., Rudman, I. W., & Mattson, D. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230101 · Cited by 1,555
Normal growth and development in the absence of hepatic insulin-like growth factor I
Yakar, S., Liu, J.-L., Stannard, B., Butler, A., Accili, D., Sauer, B., & LeRoith, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7324 · Cited by 1,420
The Somatomedin Hypothesis: 2001
Le Roith, D., Bondy, C., Yakar, S., Liu, J.-L., & Butler, A. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.1.0419 · Cited by 1,257
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252 · cited 2×
“, 2001), insulin receptor substrate-1 (IRS-1) and IRS-2 (Araki et al., 1994; Tamemoto et al., 1994).”
Research works printed but not linked: 9
- Aperghis M, 2004, Two weeks of GH administration does not increase the expression of insulin‐like growth factor‐I mRNA splice variants in the skeletal muscle of young men, J Physiol, 558, C4
- 10.1210/jc.86.11.5176 · doi:10.1210/jc.86.11.5176
- 10.3181/00379727-185-42561 · doi:10.3181/00379727-185-42561
- 10.1210/en.139.6.2824 · doi:10.1210/en.139.6.2824
- 10.1210/me.6.8.1227 · doi:10.1210/me.6.8.1227
- 10.1038/ncpendmet0195 · doi:10.1038/ncpendmet0195
- Stickland NC, 1981, Muscle development in the human fetus as exemplified by m sartorius: a quantitative study, J Anat, 132, 557
- 10.1210/jc.81.1.421 · doi:10.1210/jc.81.1.421
- 10.1210/jc.81.9.3239 · doi:10.1210/jc.81.9.3239
Cited by
Maltais, F., Decramer, M., Casaburi, R., Barreiro, E., Burelle, Y., Debigaré, R., Dekhuijzen, P. N. R., Franssen, F., Gayan-Ramirez, G., Gea, J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0373st · Cited by 1,090
Schoenfeld, B. J. (2013) · Sports Medicine · doi:10.1007/s40279-013-0017-1 · Cited by 495
Biomarkers in Sports and Exercise: Tracking Health, Performance, and Recovery in Athletes
Lee, E. C., Fragala, M. S., Kavouras, S. A., Queen, R. M., Pryor, J. L., & Casa, D. J. (2017) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000002122 · Cited by 466
Skeletal Muscle as an Endocrine Organ: The Role of Myokines in Exercise Adaptations
Hoffmann, C., & Weigert, C. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029793 · Cited by 393
Fuentes, E. N., Valdés, J. A., Molina, A., & Björnsson, B. T. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.06.009 · Cited by 337
Frailty and Protein-Energy Wasting in Elderly Patients with End Stage Kidney Disease
Kim, J. C., Kalantar-Zadeh, K., & Kopple, J. D. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010047 · Cited by 301
Cancer cachexia—pathophysiology and management
Suzuki, H., Asakawa, A., Amitani, H., Nakamura, N., & Inui, A. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0787-0 · Cited by 268
Hypothalamic control of energy expenditure and thermogenesis
Tran, L. T., Park, S., Kim, S. K., Lee, J. S., Kim, K. W., & Kwon, O. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00741-z · Cited by 208
Physical Exercise in the Oldest Old
Valenzuela, P. L., Castillo‐García, A., Morales, J. S., Izquierdo, M., Serra‐Rexach, J. A., Santos‐Lozano, A., & Lucia, A. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c190002 · Cited by 152
Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies
Baig, M. H., Ahmad, K., Moon, J. S., Park, S.-Y., Ho Lim, J., Chun, H. J., Qadri, A. F., Hwang, Y. C., Jan, A. T., Ahmad, S. S., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.876078 · Cited by 135
“As a result of stimulation of insulin-like growth factor-1 (IGF-1) production via the liver JAKSTAT pathway, GH stimulates muscle fiber hypertrophy by enhancing the synthesis of proteins associated with MSC proliferation (Velloso, 2008).”
BackgroundBond, P. (2016) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-016-0118-y · Cited by 121
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
Rodgers, B. D., & Ward, C. W. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab030 · Cited by 111
Lamon, S., Morabito, A., Arentson‐Lantz, E., Knowles, O., Vincent, G. E., Condo, D., Alexander, S. E., Garnham, A., Paddon‐Jones, D., & Aisbett, B. (2021) · Physiological Reports · doi:10.14814/phy2.14660 · Cited by 110
Aguilar‐Agon, K. W., Capel, A. J., Martin, N. R. W., Player, D. J., & Lewis, M. P. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28923 · Cited by 84
Schoenfeld, B. J. (2013) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e31828ddd53 · Cited by 74
Jiang, Q., Lou, K., Hou, L., Lu, Y., Sun, L., Tan, S. C., Low, T. Y., Kord-Varkaneh, H., & Pang, S. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102360 · Cited by 71
Anderson, L. J., Tamayose, J. M., & Garcia, J. M. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.06.010 · Cited by 70
Chen, M.-C., Hsu, W.-L., Hwang, P.-A., Chen, Y.-L., & Chou, T.-C. (2016) · Oncotarget · doi:10.18632/oncotarget.9958 · Cited by 69
“Several studies have indicated that IGF-1 can stimulate protein synthesis and muscle growth by activating PI3K/Akt/mTOR/ p70S6K/4EBP-1 signalling [31-33].”
BackgroundKnowles, O. E., Aisbett, B., Main, L. C., Drinkwater, E. J., Orellana, L., & Lamon, S. (2019) · Sports Medicine · doi:10.1007/s40279-019-01132-7 · Cited by 48
Chen, M.-C., Chen, Y.-L., Lee, C.-F., Hung, C.-H., & Chou, T.-C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143594 · Cited by 45
Determination and regulation of body composition in elite athletes
Sonksen, P. (2018) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-096742 · Cited by 23
Ives, S. J., Norton, C., Miller, V., Minicucci, O., Robinson, J., O'Brien, G., Escudero, D., Paul, M., Sheridan, C., Curran, K., et al. (2017) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2016.10.002 · Cited by 18
Yang, C.-W., Li, T.-C., Li, C.-I., Liu, C.-S., Lin, C.-H., Lin, W.-Y., & Lin, C.-C. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.11.015 · Cited by 18
Therapeutic potential of ghrelin treatment for unloading-induced muscle atrophy in mice
Koshinaka, K., Toshinai, K., Mohammad, A., Noma, K., Oshikawa, M., Ueno, H., Yamaguchi, H., & Nakazato, M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.086 · Cited by 16
Gender and exercise in relation to obesity in Greek elderly population
Papadopoulou, S. K., Papandreou, D., Tassoulas, E., Biskanaki, F., Kalogiannis, S., & Hassapidou, M. N. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186575 · Cited by 9
Metadata
- Authors
- Velloso, C. P.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-06
- Volume
- 154
- Issue
- 3
- Pages
- 557-568
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W253642632
- Cited by
- 442
- References
- 112
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.